(2S)-N-[(1S)-1-[4-carbamoyl-2-(4-fluorophenyl)-1H-imidazol-5-yl]-7-oxo-nonyl]-6-ethyl-6-azaspiro[2.5]octane-2-carboxamide

ID: ALA4785376

PubChem CID: 162665723

Max Phase: Preclinical

Molecular Formula: C29H40FN5O3

Molecular Weight: 525.67

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CCC(=O)CCCCC[C@H](NC(=O)[C@H]1CC12CCN(CC)CC2)c1[nH]c(-c2ccc(F)cc2)nc1C(N)=O

Standard InChI:  InChI=1S/C29H40FN5O3/c1-3-21(36)8-6-5-7-9-23(32-28(38)22-18-29(22)14-16-35(4-2)17-15-29)24-25(26(31)37)34-27(33-24)19-10-12-20(30)13-11-19/h10-13,22-23H,3-9,14-18H2,1-2H3,(H2,31,37)(H,32,38)(H,33,34)/t22-,23+/m1/s1

Standard InChI Key:  QEADHPNYEASZRQ-PKTZIBPZSA-N

Molfile:  

 
     RDKit          2D

 38 41  0  0  0  0  0  0  0  0999 V2000
   34.8214  -25.5063    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.2300  -26.2162    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.0431  -26.2187    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.4537  -25.5131    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   36.0492  -24.8032    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.2300  -24.7990    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.4187  -24.0658    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.4175  -24.8895    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.1297  -25.2985    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.8435  -24.8890    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.8407  -24.0622    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.1279  -23.6528    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.5487  -23.6485    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.3006  -23.9780    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   31.8493  -23.3687    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.4339  -22.6584    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.6311  -22.8314    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   32.6665  -23.4510    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.0016  -24.2005    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   33.1443  -22.7840    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.7634  -21.9064    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.5799  -21.8179    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   31.2805  -21.2430    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   33.9614  -22.8664    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.4434  -22.1993    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.2606  -22.2817    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.7384  -21.6187    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.5556  -21.7011    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.0375  -21.0340    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.8949  -22.4505    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   37.8547  -21.1164    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.8188  -24.2828    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.1540  -25.0322    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.3008  -23.6158    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   27.7054  -25.2975    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   34.0724  -25.8482    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.2750  -25.5168    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.6804  -26.2264    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  6  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12  7  1  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 13  2  0
 11 13  1  0
 15 18  1  0
 18 19  1  6
 18 20  1  0
 16 21  1  0
 21 22  1  0
 21 23  2  0
 20 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 28 30  2  0
 29 31  1  0
 19 32  1  0
 33 32  1  6
 32 34  2  0
  8 35  1  0
 36 33  1  0
  1 36  1  0
 33  1  1  0
  4 37  1  0
 37 38  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4785376

    ---

Associated Targets(Human)

HDAC1 Tclin Class 1 histone deacetylase (459 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HDAC8 Tclin Histone deacetylase 8 (4516 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HDAC6 Tclin Histone deacetylase 6 (20808 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HDAC2 Tclin Histone deacetylase 2 (3971 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HDAC3 Tclin Histone deacetylase 3 (3654 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HDAC1 Tclin Histone deacetylase 1 (10854 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Human immunodeficiency virus (3636 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 525.67Molecular Weight (Monoisotopic): 525.3115AlogP: 4.52#Rotatable Bonds: 13
Polar Surface Area: 121.18Molecular Species: BASEHBA: 5HBD: 3
#RO5 Violations: 1HBA (Lipinski): 8HBD (Lipinski): 4#RO5 Violations (Lipinski): 1
CX Acidic pKa: 9.35CX Basic pKa: 9.00CX LogP: 3.01CX LogD: 1.79
Aromatic Rings: 2Heavy Atoms: 38QED Weighted: 0.33Np Likeness Score: -0.43

References

1. Clausen DJ,Liu J,Yu W,Duffy JL,Chung CC,Myers RW,Klein DJ,Fells J,Holloway K,Wu J,Wu G,Howell BJ,Barnard RJO,Kozlowski J.  (2020)  Development of a selective HDAC inhibitor aimed at reactivating the HIV latent reservoir.,  30  (17.0): [PMID:32738976] [10.1016/j.bmcl.2020.127367]
2. Yu W, Fells J, Clausen D, Liu J, Klein DJ, Christine Chung C, Myers RW, Wu J, Wu G, Howell BJ, Barnard RJO, Kozlowski J..  (2021)  Discovery of macrocyclic HDACs 1, 2, and 3 selective inhibitors for HIV latency reactivation.,  47  [PMID:34091041] [10.1016/j.bmcl.2021.128168]

Source